A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy (X-TOLE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03796962 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 8, 2019
Last Update Posted : April 19, 2024
|
Sponsor:
Xenon Pharmaceuticals Inc.
Collaborator:
Novotech Health Holdings Pte. Ltd.
Information provided by (Responsible Party):
Xenon Pharmaceuticals Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | September 2, 2021 |
| Estimated Study Completion Date : | October 2028 |
| Certification/Extension First Submitted : | August 18, 2022 |